Xeris Biopharma (XERS) News Today $7.49 -0.19 (-2.47%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$7.48 -0.02 (-0.20%) As of 09/12/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XERS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Xeris Biopharma (NASDAQ:XERS) Director Sells $119,660.00 in Stock1 hour ago | insidertrades.comFred Alger Management LLC Buys New Stake in Xeris Biopharma Holdings, Inc. $XERS4 hours ago | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Consensus Recommendation of "Moderate Buy" by AnalystsSeptember 12 at 2:40 AM | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Sees Significant Decline in Short InterestSeptember 9, 2025 | americanbankingnews.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Short Interest Down 26.7% in AugustSeptember 9, 2025 | marketbeat.comParkman Healthcare Partners LLC Has $9.78 Million Stock Position in Xeris Biopharma Holdings, Inc. $XERSSeptember 8, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Downgraded by Wall Street Zen to BuySeptember 8, 2025 | marketbeat.comCubist Systematic Strategies LLC Takes Position in Xeris Biopharma Holdings, Inc. $XERSSeptember 7, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. $XERS Stock Holdings Raised by Graham Capital Management L.P.September 7, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Stock Rating Lowered by Wall Street ZenSeptember 7, 2025 | americanbankingnews.comBosun Asset Management LLC Acquires New Holdings in Xeris Biopharma Holdings, Inc. $XERSSeptember 6, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Reaches New 12-Month High - Time to Buy?September 5, 2025 | marketbeat.comXeris In Recorlev-Fuelled Growth: Why I Choose To BuySeptember 5, 2025 | seekingalpha.comPDT Partners LLC Buys New Shares in Xeris Biopharma Holdings, Inc. $XERSSeptember 5, 2025 | marketbeat.comIeq Capital LLC Boosts Holdings in Xeris Biopharma Holdings, Inc. $XERSSeptember 5, 2025 | marketbeat.comQuarry LP Makes New $388,000 Investment in Xeris Biopharma Holdings, Inc. $XERSSeptember 3, 2025 | marketbeat.comAlpine Global Management LLC Has $549,000 Stock Position in Xeris Biopharma Holdings, Inc. $XERSSeptember 2, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. $XERS Shares Purchased by Driehaus Capital Management LLCSeptember 2, 2025 | marketbeat.comWellington Management Group LLP Has $2.15 Million Stake in Xeris Biopharma Holdings, Inc. $XERSSeptember 2, 2025 | marketbeat.comRussell Investments Group Ltd. Buys 113,713 Shares of Xeris Biopharma Holdings, Inc. $XERSSeptember 1, 2025 | marketbeat.comJeffrey Sherman Sells 42,232 Shares of Xeris Biopharma (NASDAQ:XERS) StockAugust 30, 2025 | insidertrades.comQuantbot Technologies LP Purchases Shares of 54,107 Xeris Biopharma Holdings, Inc. $XERSAugust 30, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. $XERS Stake Increased by Invesco Ltd.August 30, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 RevenueAugust 29, 2025 | uk.finance.yahoo.comWalleye Capital LLC Invests $3.80 Million in Xeris Biopharma Holdings, Inc. $XERSAugust 29, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. $XERS Holdings Raised by Jump Financial LLCAugust 29, 2025 | marketbeat.comVanguard Group Inc. Purchases 210,581 Shares of Xeris Biopharma Holdings, Inc. $XERSAugust 28, 2025 | marketbeat.comStonepine Capital Management LLC Sells 80,052 Shares of Xeris Biopharma Holdings, Inc. $XERSAugust 26, 2025 | marketbeat.comXeris Announces Orange Book Listing of U.S. Patent for Recorlev®August 25, 2025 | finance.yahoo.comXeris Biopharma (NASDAQ:XERS) Stock Price Expected to Rise, Leerink Partners Analyst SaysAugust 24, 2025 | marketbeat.comFY2025 EPS Estimates for Xeris Biopharma Boosted by AnalystAugust 24, 2025 | marketbeat.comNuveen LLC Buys New Shares in Xeris Biopharma Holdings, Inc. $XERSAugust 24, 2025 | marketbeat.comCetera Investment Advisers Buys New Shares in Xeris Biopharma Holdings, Inc. $XERSAugust 24, 2025 | marketbeat.comQ3 EPS Estimates for Xeris Biopharma Decreased by AnalystAugust 23, 2025 | marketbeat.comVoss Capital LP Makes New Investment in Xeris Biopharma Holdings, Inc. $XERSAugust 21, 2025 | marketbeat.comDeutsche Bank AG Grows Position in Xeris Biopharma Holdings, Inc. $XERSAugust 19, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Average Rating of "Moderate Buy" by AnalystsAugust 18, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director John Johnson Sells 107,500 SharesAugust 17, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Sets New 52-Week High - Here's WhyAugust 17, 2025 | marketbeat.comJohn Johnson Sells 107,500 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) StockAugust 16, 2025 | insidertrades.comHC Wainwright Estimates Xeris Biopharma Q3 EarningsAugust 16, 2025 | marketbeat.comInsider Selling: Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director Sells 42,500 Shares of StockAugust 15, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Purchases 418,139 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)August 15, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director Sells $309,400.00 in StockAugust 14, 2025 | insidertrades.comXeris Biopharma's (XERS) "Buy" Rating Reaffirmed at HC WainwrightAugust 13, 2025 | marketbeat.comInformed Momentum Co LLC Grows Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)August 13, 2025 | marketbeat.comXeris Biopharma assumed with a Buy at H.C. WainwrightAugust 12, 2025 | msn.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) is Knott David M Jr's 7th Largest PositionAugust 12, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Releases Earnings Results, Beats Expectations By $0.02 EPSAugust 10, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Upgraded to "Strong-Buy" at Wall Street ZenAugust 10, 2025 | marketbeat.com Get Xeris Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XERS Media Mentions By Week XERS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XERS News Sentiment▼1.110.93▲Average Medical News Sentiment XERS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XERS Articles This Week▼114▲XERS Articles Average Week Get the Latest News and Ratings for XERS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Xeris Biopharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CRSP News PTCT News KRYS News PCVX News ACAD News ACLX News ADMA News ARWR News MENS News MIRM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XERS) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xeris Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xeris Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XERS Stock Alerts